Compass Pathways Plc Adr stock is traded at $8.61, with a volume of 3,751,506. It is up +10.24% in the last 24 hours and down -25.52% over the past month. Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Previous Close:
$7.81
Open:
$8.05
24h Volume:
3,751,506
Relative Volume:
0.77
Market Cap:
$1.22B
Revenue:
-
Net Income/Loss:
-$191.97M
P/E Ratio:
-
EPS:
-$3.16
Net Cash Flow:
-$159.63M
1W Performance:
-25.58%
1M Performance:
-25.52%
6M Performance:
-11.78%
1Y Performance:
+54.03%
1-Day Range:
$7.99$8.68
1-Week Range:
$7.54$11.76
52-Week Range:
$4.88$15.87
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Name
Compass Pathways Plc AdrSector
HealthcareIndustry
Medical Care FacilitiesPhone
1-716-676-6461Address
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE, United KingdomMarket Cap
Revenue
Net Income
Cash Flow
EPS